These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 20147862)

  • 1. Imaging of radioiodine-labeled KH901, a tumor-specific oncolytic recombinant adenovirus, in nude mice with human hepatocellular carcinoma.
    Mi YX; Li YC; Long YH
    Nucl Med Commun; 2010 May; 31(5):405-10. PubMed ID: 20147862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Antitumor effects of radioiodine labeled KH901 on nude mice bearing hepatoma].
    Mi Y; Li Y; Long Y
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2010 Apr; 27(2):389-94. PubMed ID: 20481325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Iodination conditions of KH901, a tumor-specific oncolytic recombinant adenovirus, and its 125I-labeled compounds biodistribution in animals].
    Mi Y; Li Y; Long Y; Xie P
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2009 Oct; 26(5):1064-6, 1093. PubMed ID: 19947491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Tumor-selective replication, cytotoxicity and GM-CSF production of oncolytic recombinant adenovirus in KH901 injection].
    Shen FB; Chang JH; Yang C; Li J; Guo Y; Yi B; Li HX; Ye XF; Wang L
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Jan; 38(1):31-4. PubMed ID: 17294722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effects of KH901, a tumor-specific oncolytic recombinant adenovirus, on antitumor and expressing GM-CSF in xenograft tumor models].
    Shen FB; Yang C; Lei N; Ju Q; Guo Y; Yi B; Luo ZX; Li HX; Wang L
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Jun; 38(3):386-90. PubMed ID: 17593813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Phase I study of KH901, a conditionally replicating granulocyte-macrophage colony-stimulating factor: armed oncolytic adenovirus for the treatment of head and neck cancers.
    Chang J; Zhao X; Wu X; Guo Y; Guo H; Cao J; Guo Y; Lou D; Yu D; Li J
    Cancer Biol Ther; 2009 Apr; 8(8):676-82. PubMed ID: 19242097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Establishment of a human hepatocellular carcinoma cell line highly expressing sodium iodide symporter for radionuclide gene therapy.
    Kang JH; Chung JK; Lee YJ; Shin JH; Jeong JM; Lee DS; Lee MC
    J Nucl Med; 2004 Sep; 45(9):1571-6. PubMed ID: 15347726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oncolytic Activity of a Novel Influenza A Virus Carrying Granulocyte-Macrophage Colony-Stimulating Factor in Hepatocellular Carcinoma.
    Penghui Y; Fang S; Ruilan W; Guanglin L; Hongjing G; Yueqiang D; Zhongpeng Z; Xiaolan Y; Zhaohai W; Shaogeng Z; Xiliang W
    Hum Gene Ther; 2019 Mar; 30(3):330-338. PubMed ID: 30205709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A simplified system for generating oncolytic adenovirus vector carrying one or two transgenes.
    Hu ZB; Wu CT; Wang H; Zhang QW; Wang L; Wang RL; Lu ZZ; Wang LS
    Cancer Gene Ther; 2008 Mar; 15(3):173-82. PubMed ID: 18157145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenovirus armed with VGLL4 selectively kills hepatocellular carcinoma with G2/M phase arrest and apoptosis promotion.
    Xie W; Hao J; Zhang K; Fang X; Liu X
    Biochem Biophys Res Commun; 2018 Sep; 503(4):2758-2763. PubMed ID: 30119884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatoma targeting peptide conjugated bio-reducible polymer complexed with oncolytic adenovirus for cancer gene therapy.
    Choi JW; Kim HA; Nam K; Na Y; Yun CO; Kim S
    J Control Release; 2015 Dec; 220(Pt B):691-703. PubMed ID: 26437261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro and in vivo activities of an oncolytic adenoviral vector designed to express GM-CSF.
    Bristol JA; Zhu M; Ji H; Mina M; Xie Y; Clarke L; Forry-Schaudies S; Ennist DL
    Mol Ther; 2003 Jun; 7(6):755-64. PubMed ID: 12788649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CG0070, a conditionally replicating granulocyte macrophage colony-stimulating factor--armed oncolytic adenovirus for the treatment of bladder cancer.
    Ramesh N; Ge Y; Ennist DL; Zhu M; Mina M; Ganesh S; Reddy PS; Yu DC
    Clin Cancer Res; 2006 Jan; 12(1):305-13. PubMed ID: 16397056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased safety with preserved antitumoral efficacy on hepatocellular carcinoma with dual-regulated oncolytic adenovirus.
    Zhang Q; Chen G; Peng L; Wang X; Yang Y; Liu C; Shi W; Su C; Wu H; Liu X; Wu M; Qian Q
    Clin Cancer Res; 2006 Nov; 12(21):6523-31. PubMed ID: 17085667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of hepatocellular carcinoma by AdAFPep/rep, AdAFPep/p53, and 5-fluorouracil in mice.
    Sagawa T; Yamada Y; Takahashi M; Sato Y; Kobune M; Takimoto R; Fukaura J; Iyama S; Sato T; Miyanishi K; Matsunaga T; Takayama T; Kato J; Sasaki K; Hamada H; Niitsu Y
    Hepatology; 2008 Sep; 48(3):828-40. PubMed ID: 18756484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Use of 99mTc-survivin antisense oligonucleotide in diagnosis of hepatocellular carcinoma: an experiment with mice].
    Gao ZR; Zhang YX; Zhang KJ
    Zhonghua Yi Xue Za Zhi; 2005 Aug; 85(33):2327-30. PubMed ID: 16321225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An oncolytic adenovirus expressing granulocyte macrophage colony-stimulating factor shows improved specificity and efficacy for treating human solid tumors.
    Lei N; Shen FB; Chang JH; Wang L; Li H; Yang C; Li J; Yu DC
    Cancer Gene Ther; 2009 Jan; 16(1):33-43. PubMed ID: 18670453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Augmenting the antitumor effect of TRAIL by SOCS3 with double-regulated replicating oncolytic adenovirus in hepatocellular carcinoma.
    Wei RC; Cao X; Gui JH; Zhou XM; Zhong D; Yan QL; Huang WD; Qian QJ; Zhao FL; Liu XY
    Hum Gene Ther; 2011 Sep; 22(9):1109-19. PubMed ID: 21361790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic gene-directed enzyme prodrug therapy of hepatocellular carcinoma using a targeted adenovirus armed with carboxypeptidase G2.
    Schepelmann S; Hallenbeck P; Ogilvie LM; Hedley D; Friedlos F; Martin J; Scanlon I; Hay C; Hawkins LK; Marais R; Springer CJ
    Cancer Res; 2005 Jun; 65(12):5003-8. PubMed ID: 15958540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oncolytic adenovirus SG600-IL24 selectively kills hepatocellular carcinoma cell lines.
    Xue XB; Xiao CW; Zhang H; Lu AG; Gao W; Zhou ZQ; Guo XL; Zhong MA; Yang Y; Wang CJ
    World J Gastroenterol; 2010 Oct; 16(37):4677-84. PubMed ID: 20872968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.